Transactions
IPA Europe, a subsidiary of ImmunoPrecise Antibodies, acquired by AVS Bio
Aug. 2025
Client: IPA Europe offers a comprehensive suite of antibody discovery, engineering, and characterization services. In addition to its industry-leading hybridoma and B-cell screening platforms, the Company has deep expertise in recombinant protein expression and offers scalable protein production for both research and pre-clinical applications.
Role: Edgemont Partners acted as exclusive financial advisor to ImmunoPrecise Antibodies on its divestiture of its Netherlands subsidiary, IPA Europe, to AVS Bio, a portfolio company of Arlington Capital Partners
Sector: Pharmaceutical Services
Lead Banker: Andrew Karlin
acquired by
